nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Spironolactone—dilated cardiomyopathy	0.441	1	CrCtD
Fluoxymesterone—SHBG—Spironolactone—dilated cardiomyopathy	0.102	0.422	CbGbCtD
Fluoxymesterone—AR—Spironolactone—dilated cardiomyopathy	0.0856	0.353	CbGbCtD
Fluoxymesterone—NR3C1—Spironolactone—dilated cardiomyopathy	0.0544	0.225	CbGbCtD
Fluoxymesterone—Eplerenone—Spironolactone—dilated cardiomyopathy	0.0325	0.11	CrCrCtD
Fluoxymesterone—Oxandrolone—Spironolactone—dilated cardiomyopathy	0.0305	0.103	CrCrCtD
Fluoxymesterone—Dydrogesterone—Spironolactone—dilated cardiomyopathy	0.0259	0.0876	CrCrCtD
Fluoxymesterone—Potassium Canrenoate—Spironolactone—dilated cardiomyopathy	0.0246	0.0835	CrCrCtD
Fluoxymesterone—Megestrol acetate—Spironolactone—dilated cardiomyopathy	0.0225	0.0764	CrCrCtD
Fluoxymesterone—Medroxyprogesterone Acetate—Spironolactone—dilated cardiomyopathy	0.02	0.0679	CrCrCtD
Fluoxymesterone—Hydrocortamate—Spironolactone—dilated cardiomyopathy	0.0181	0.0613	CrCrCtD
Fluoxymesterone—Cortisone acetate—Spironolactone—dilated cardiomyopathy	0.0175	0.0594	CrCrCtD
Fluoxymesterone—Testolactone—Spironolactone—dilated cardiomyopathy	0.017	0.0577	CrCrCtD
Fluoxymesterone—Progesterone—Spironolactone—dilated cardiomyopathy	0.0152	0.0516	CrCrCtD
Fluoxymesterone—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.0152	0.0516	CrCrCtD
Fluoxymesterone—Fludrocortisone—Spironolactone—dilated cardiomyopathy	0.0152	0.0516	CrCrCtD
Fluoxymesterone—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.0148	0.0503	CrCrCtD
Fluoxymesterone—Testosterone—Spironolactone—dilated cardiomyopathy	0.0132	0.0448	CrCrCtD
Fluoxymesterone—Hydrocortisone—Spironolactone—dilated cardiomyopathy	0.0124	0.0421	CrCrCtD
Fluoxymesterone—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00144	0.168	CcSEcCtD
Fluoxymesterone—PRLR—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.00109	0.0961	CbGpPWpGaD
Fluoxymesterone—Blood cholesterol increased—Furosemide—dilated cardiomyopathy	0.00107	0.126	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.000904	0.106	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.000711	0.0833	CcSEcCtD
Fluoxymesterone—ESR1—LKB1 signaling events—SIK1—dilated cardiomyopathy	0.000591	0.0522	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	0.000517	0.0457	CbGpPWpGaD
Fluoxymesterone—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000492	0.0576	CcSEcCtD
Fluoxymesterone—Eplerenone—NR3C2—dilated cardiomyopathy	0.000397	0.224	CrCbGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—LAMA4—dilated cardiomyopathy	0.000372	0.0329	CbGpPWpGaD
Fluoxymesterone—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000369	0.0432	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000366	0.0324	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—LMNA—dilated cardiomyopathy	0.000364	0.0322	CbGpPWpGaD
Fluoxymesterone—Fludrocortisone—NR3C2—dilated cardiomyopathy	0.000359	0.202	CrCbGaD
Fluoxymesterone—Alopecia—Spironolactone—dilated cardiomyopathy	0.000353	0.0413	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000351	0.0311	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	0.000343	0.0303	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000329	0.0291	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000324	0.038	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000283	0.0332	CcSEcCtD
Fluoxymesterone—Spironolactone—NR3C2—dilated cardiomyopathy	0.000271	0.153	CrCbGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000271	0.0239	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000267	0.0236	CbGpPWpGaD
Fluoxymesterone—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000254	0.0297	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000254	0.0224	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.00025	0.0221	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000243	0.0285	CcSEcCtD
Fluoxymesterone—Prednisolone—NR3C2—dilated cardiomyopathy	0.000236	0.133	CrCbGaD
Fluoxymesterone—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000234	0.0274	CcSEcCtD
Fluoxymesterone—Betamethasone—NR3C2—dilated cardiomyopathy	0.000231	0.13	CrCbGaD
Fluoxymesterone—PRLR—Adipogenesis—FAS—dilated cardiomyopathy	0.000213	0.0188	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000209	0.0245	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000207	0.0183	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000204	0.018	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—AGT—dilated cardiomyopathy	0.000199	0.0176	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—EGFR—dilated cardiomyopathy	0.000197	0.0175	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—PSEN2—dilated cardiomyopathy	0.000189	0.0167	CbGpPWpGaD
Fluoxymesterone—Headache—Spironolactone—dilated cardiomyopathy	0.000178	0.0208	CcSEcCtD
Fluoxymesterone—Nausea—Spironolactone—dilated cardiomyopathy	0.000168	0.0197	CcSEcCtD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	0.00016	0.0141	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000157	0.0139	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000154	0.0181	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000148	0.0131	CbGpPWpGaD
Fluoxymesterone—Progesterone—NR3C2—dilated cardiomyopathy	0.000147	0.0827	CrCbGaD
Fluoxymesterone—Alopecia—Lisinopril—dilated cardiomyopathy	0.000144	0.0169	CcSEcCtD
Fluoxymesterone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000138	0.0162	CcSEcCtD
Fluoxymesterone—Dexamethasone—NR3C2—dilated cardiomyopathy	0.000134	0.0756	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.000132	0.0117	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.00013	0.0115	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000122	0.0108	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.000122	0.0108	CbGpPWpGaD
Fluoxymesterone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00012	0.0141	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000116	0.0136	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000114	0.0133	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000112	0.00991	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	0.000106	0.00938	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000104	0.0122	CcSEcCtD
Fluoxymesterone—Headache—Furosemide—dilated cardiomyopathy	9.66e-05	0.0113	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	9.54e-05	0.00843	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	9.41e-05	0.00832	CbGpPWpGaD
Fluoxymesterone—Nausea—Furosemide—dilated cardiomyopathy	9.16e-05	0.0107	CcSEcCtD
Fluoxymesterone—PRLR—Adipogenesis—TNF—dilated cardiomyopathy	9.03e-05	0.00798	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	8.53e-05	0.00999	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	8.44e-05	0.00747	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	8.43e-05	0.00745	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—EGFR—dilated cardiomyopathy	8.37e-05	0.0074	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	8.3e-05	0.00734	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	7.48e-05	0.00662	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	7.31e-05	0.00646	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—RPS6KB1—dilated cardiomyopathy	7.28e-05	0.00644	CbGpPWpGaD
Fluoxymesterone—Headache—Lisinopril—dilated cardiomyopathy	7.25e-05	0.00849	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	7.2e-05	0.00637	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	6.92e-05	0.00612	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—RAC1—dilated cardiomyopathy	6.88e-05	0.00609	CbGpPWpGaD
Fluoxymesterone—Nausea—Lisinopril—dilated cardiomyopathy	6.87e-05	0.00805	CcSEcCtD
Fluoxymesterone—ESR1—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	6.87e-05	0.00608	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—LMNA—dilated cardiomyopathy	6.73e-05	0.00595	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	6.73e-05	0.00595	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	6.51e-05	0.00575	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	6.41e-05	0.00566	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	6.14e-05	0.00543	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—RAC1—dilated cardiomyopathy	6.08e-05	0.00538	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	6.07e-05	0.00537	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	6.05e-05	0.00535	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	5.96e-05	0.00527	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	5.77e-05	0.0051	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	5e-05	0.00442	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.74e-05	0.00419	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	4.68e-05	0.00413	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	4.6e-05	0.00407	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ITGB1—dilated cardiomyopathy	4.59e-05	0.00406	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	4.51e-05	0.00399	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	4.37e-05	0.00387	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.21e-05	0.00372	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.21e-05	0.00372	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	4.09e-05	0.00361	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	4.03e-05	0.00356	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.95e-05	0.00349	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—FAS—dilated cardiomyopathy	3.93e-05	0.00348	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.91e-05	0.00346	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD36—dilated cardiomyopathy	3.91e-05	0.00346	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.89e-05	0.00344	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	3.81e-05	0.00337	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.81e-05	0.00337	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	3.79e-05	0.00335	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.79e-05	0.00335	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.74e-05	0.0033	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—RAC1—dilated cardiomyopathy	3.69e-05	0.00326	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—AGT—dilated cardiomyopathy	3.68e-05	0.00326	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	3.47e-05	0.00307	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.24e-05	0.00286	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	3.13e-05	0.00277	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.07e-05	0.00271	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.04e-05	0.00269	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	2.99e-05	0.00264	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	2.94e-05	0.0026	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.94e-05	0.0026	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NR3C2—dilated cardiomyopathy	2.92e-05	0.00258	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	2.89e-05	0.00256	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.88e-05	0.00254	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.64e-05	0.00233	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.48e-05	0.00219	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—RAF1—dilated cardiomyopathy	2.44e-05	0.00216	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RAC1—dilated cardiomyopathy	2.38e-05	0.00211	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	2.29e-05	0.00203	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AGT—dilated cardiomyopathy	2.28e-05	0.00201	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	2.25e-05	0.00199	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	2.22e-05	0.00196	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	2.05e-05	0.00181	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.91e-05	0.00169	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.9e-05	0.00168	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NPPA—dilated cardiomyopathy	1.83e-05	0.00162	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.7e-05	0.0015	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—dilated cardiomyopathy	1.68e-05	0.00148	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	1.67e-05	0.00148	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.62e-05	0.00143	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RAF1—dilated cardiomyopathy	1.58e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	1.58e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	1.57e-05	0.00139	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.44e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	1.41e-05	0.00125	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	1.39e-05	0.00123	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.31e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.25e-05	0.0011	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—dilated cardiomyopathy	1.08e-05	0.000958	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.9e-06	0.000787	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.9e-06	0.000699	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.9e-06	0.000699	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.35e-06	0.00065	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.12e-06	0.000629	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.08e-06	0.000537	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.77e-06	0.00051	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.95e-06	0.000438	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.48e-06	0.000396	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	4.28e-06	0.000378	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.97e-06	0.000262	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.04e-06	0.00018	CbGpPWpGaD
